FREE SHIPPING ON ORDERS OVER $150

l-carnitine androgen receptor upregulation improves polycystic ovary syndrome by increasing CYP11A1, estrogen receptor, and decreasing XNIP and VEGF expression | Naunyn-Schmiedeberg's Archives of Pharmacology Frontiers | Androgen Receptor Signaling

$24.51

Quantity
- +
Description

American Journal of Kidney Diseases (2003)

l-carnitine androgen receptor upregulation improves polycystic ovary syndrome by increasing CYP11A1, estrogen receptor, and decreasing XNIP and VEGF expression | Naunyn-Schmiedeberg's Archives of Pharmacology Frontiers | Androgen Receptor Signaling

J Pharmacol Exp Ther 1993

l-carnitine androgen receptor upregulation improves polycystic ovary syndrome by increasing CYP11A1, estrogen receptor, and decreasing XNIP and VEGF expression | Naunyn-Schmiedeberg's Archives of Pharmacology Frontiers | Androgen Receptor Signaling

and serum levels of albumin, pre-albumin, totalcholesterol, free carnitine, folic acid, and trace elements

l-carnitine androgen receptor upregulation improves polycystic ovary syndrome by increasing CYP11A1, estrogen receptor, and decreasing XNIP and VEGF expression | Naunyn-Schmiedeberg's Archives of Pharmacology Frontiers | Androgen Receptor Signaling

Does L-Carnitine improve exercise performance or recovery

l-carnitine androgen receptor upregulation improves polycystic ovary syndrome by increasing CYP11A1, estrogen receptor, and decreasing XNIP and VEGF expression | Naunyn-Schmiedeberg's Archives of Pharmacology Frontiers | Androgen Receptor Signaling

You may also like

recommand products

5-Amino-1MQ

US$ 29.18

Min. order: 1 piece

4.8 (24 reviews)

Sold : Login>>